✦ LIBER ✦

803 Integrative Marker Analysis and Risk Assessment in Stage II Colon Cancer

✍ Scribed by U. Nitsche; R. Rosenberg; T. Schuster; J. Slotta-Huspenina; F.G. Bader; H. Friess; P.M. Schlag; U. Stein; K.P. Janssen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk assessment and adjuvant systemic th

✍ Veena Shankaran; Polina Khrizman; Al B. Benson 📂 Article 📅 2009 🏛 Current Science Inc. 🌐 English ⚖ 422 KB

Integrated Analysis of Molecular and Cli

✍ Roth, A. D.; Delorenzi, M.; Tejpar, S.; Yan, P.; Klingbiel, D.; Fiocca, R.; d'Ar 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 846 KB

Is adjuvant chemotherapy beneficial to h

✍ Chun-Chi Lin; Jen-Kou Lin; Shih-Ching Chang; Huann-Sheng Wang; Shung-Haur Yang; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 189 KB

Prognostic Factors Assessed for 15,096 P

✍ Mroczkowski, Pawel; Schmidt, Uwe; Sahm, Maik; Gastinger, Ingo; Lippert, Hans; Ku 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 176 KB

Prognostic and Predictive Markers in Sta

✍ Robin K. Kelley; Alan P. Venook 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 407 KB

Adjuvant sequential methotrexate → 5-flu

✍ Bruzzi, P; Sobrero, A; Frassineti, G; Falcone, A; Dogliotti, L; Rosso, R; Di Cos 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 36 KB